rs443751
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_023077.3(COA7):āc.656A>Gā(p.Lys219Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.333 in 1,614,068 control chromosomes in the GnomAD database, including 94,528 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_023077.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.286 AC: 43441AN: 152108Hom.: 6886 Cov.: 33
GnomAD3 exomes AF: 0.287 AC: 72192AN: 251300Hom.: 11906 AF XY: 0.297 AC XY: 40294AN XY: 135804
GnomAD4 exome AF: 0.338 AC: 493802AN: 1461840Hom.: 87643 Cov.: 54 AF XY: 0.338 AC XY: 245716AN XY: 727224
GnomAD4 genome AF: 0.285 AC: 43449AN: 152228Hom.: 6885 Cov.: 33 AF XY: 0.281 AC XY: 20890AN XY: 74414
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at